The Use of Natural Agents to Counteract Telomere Shortening: Effects of a Multi-Component Extract of Astragalus mongholicus Bunge and Danazol
Isabelle Guinobert(Roche (France)), Radhia M’kacher(Genopole (France)), Lucile Berthomier(Centre National de la Recherche Scientifique), Georges Deschênes(Hôpital Robert-Debré), Bruno Colicchio(Université de Haute-Alsace), Noufϊssa Oudrhiri(Inserm), César Cotte(Roche (France)), Éric Jeandidier(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Alain Dieterlen(Université de Haute-Alsace), Isabelle Ripoche(Centre National de la Recherche Scientifique), Claude Blondeau(Fédération Internationale de l'Automobile), Patrice Carde(Institut Gustave Roussy), Valérie Bardot(Roche (France))
Cited by 12
Related Papers
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. International Collaborative Study Group for Bartter-like Syndromes [published erratum appears in Hum Mol Genet 1997 Apr;6(4):650]
|Human Molecular Genetics|1997|190
Novel Molecular Variants of the Na-K-2Cl Cotransporter Gene Are Responsible for Antenatal Bartter Syndrome
|The American Journal of Human Genetics|1998|157
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria
|Nephrology Dialysis Transplantation|2011|144